Company Encyclopedia
View More
name
iShares US Pharma
IHE.US
News
View More

Dow Jones futures up, Novo Nordisk down. Market recovery needed after recent losses. Nvidia, Apple, Eli Lilly in focus.

Following significant recent losses, the stock market is in need of a strong rebound. Investors are advised to keep a close eye on Nvidia, Apple, and Eli Lilly. Dow Jones Futures have seen a promising rise, while Novo Nordisk has experienced a significant dip. This update emphasizes the importance of monitoring these key companies for potential shifts in the market.

Unusual Whales·
US
NVDA
+2.12%
US
LLY
-1.85%
US
AAPL
-1.21%
Unusual Whales·
US
NVDA
+2.12%
US
LLY
-1.85%
US
AAPL
-1.21%

Dir O'Keefe Surrenders 603 Of Jazz Pharmaceuticals Plc [JAZZ]

Director Kenneth W. O'Keefe of Jazz Pharmaceuticals Plc surrendered 603 shares back to the company to cover option exercise costs and/or tax liabilities. The transaction was filed with the SEC on December 4, 2025, at a price of $173.07 per share, totaling $104,361. O'Keefe's ending holdings are 30,256 shares, with 25,811 direct and 4,445 indirect.

Reuters·
US
JAZZ
-0.11%
Reuters·
US
JAZZ
-0.11%

Health Care Down Sharply on Rotation to Rate-Sensitive Sectors -- Health Care Roundup

Health-care stocks fell sharply as traders shifted to rate-sensitive sectors. Halozyme secured a preliminary injunction against Merck & Co. in a patent dispute over Keytruda in Germany. The Trump administration's biomedical innovation goals face challenges within the FDA, amid infighting and staff turnover influenced by Robert F. Kennedy Jr.'s policy changes.

marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%
marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%

Small caps approach all-time highs, Eli Lilly at key level, 5 stocks in buy zones as Dow Jones futures surge. Ulta Beauty posts strong earnings. Robinhood leads new buys.

Small-cap stocks are nearing all-time highs as Dow Jones futures surge. Eli Lilly's stock is at a critical level, while Ulta Beauty reports strong earnings. Robinhood leads new stock purchases, and five stocks are in buy zones, indicating promising investment opportunities.

Unusual Whales·
US
ULTA
-1.94%
US
LLY
-1.85%
Unusual Whales·
US
ULTA
-1.94%
US
LLY
-1.85%

Zoetis Inc. Stock Underperforms Thursday When Compared To Competitors

Zoetis Inc. (ZTS) shares fell 1.76% to $120.41 on Thursday, marking the fourth consecutive day of losses. The stock underperformed compared to competitors like Merck & Co. Inc. and IDEXX Laboratories Inc. Trading volume was higher than the 50-day average. Zoetis is 33.79% below its 52-week high of $181.85. The S&P 500 rose 0.11%, while the Dow Jones fell 0.07%.

Dow Jones·
US
ZTS
-1.76%
Dow Jones·
US
ZTS
-1.76%
© 2025 Longbridge｜Disclaimer